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Lysine acetylation is a major posttranslational modi-
fication involved in a broad array of physiological
functions. Here, we provide an organ-wide map of
lysine acetylation sites from 16 rat tissues analyzed
by high-resolution tandem mass spectrometry. We
quantify 15,474 modification sites on 4,541 proteins
and provide the data set as a web-based database.
We demonstrate that lysine acetylation displays
site-specific sequence motifs that diverge between
cellular compartments, with a significant fraction of
nuclear sites conforming to the consensus motifs
G-AcK and AcK-P. Our data set reveals that the sub-
cellular acetylation distribution is tissue-type depen-
dent and that acetylation targets tissue-specific
pathways involved in fundamental physiological
processes. We compare lysine acetylation patterns
for rat as well as human skeletal muscle biopsies
and demonstrate its general involvement in muscle
contraction. Furthermore, we illustrate that acety-
lation of fructose-bisphosphate aldolase and glyc-
erol-3-phosphate dehydrogenase serves as a cellular
mechanism to switch off enzymatic activity.
INTRODUCTION
Lysine acetylation is a reversible posttranslational modification
involved in multiple cellular processes, where an acetyl group
is transferred to the epsilon-amino group of an internal lysine
residue of a protein. The importance of lysine acetylation is
well appreciated in the context of nuclear histone modifications
(Strahl and Allis, 2000), but the regulatory implications of the
modification extend beyond gene regulation. Changes in cellular
lysine acetylation status can alter metabolic enzyme activity andprovide a mechanism for the cell to adapt to metabolic changes
(Rodgers et al., 2008; Wang et al., 2010; Zhao et al., 2010), for
instance by regulating key enzymes of the tricarboxylic acid
cycle, the urea cycle, and fatty acid oxidation (Ahn et al., 2008;
Hirschey et al., 2010; Kim et al., 2006; Nakagawa et al., 2009).
The physiological importance of dynamic acetylation as a regula-
tory mechanism of metabolism has been highlighted in recent
studies of the liver (Zhao et al., 2010), where the distribution of
lysine acetylation sites changes under conditions of either acute
fasting (Yang et al., 2011) or caloric restriction (Schwer et al.,
2009). An overlap of 70% has been reported for acetylation
sites identified from mouse and human liver tissues, whereas
the overlap with data from cell lines was only 14% (Zhao et al.,
2010). Because lysine acetylation sites are evolutionarily
conserved (Wang et al., 2010; Weinert et al., 2011), this suggests
that acetylation patterns vary depending on the particular cellular
functions to be performed. To explore physiologically relevant
lysine acetylation substrates, it is pivotal to have knowledge of
which proteins are acetylated in vivo and to know the tissue
distribution of themodified sites. The value of creating extensive,
tissue-specific maps of protein lysine acetylation sites is further
underscored by the significant role of posttranslational modifi-
cations in the evolution and phenotypic composition of verte-
brates, as indicated by the significant selective pressure gene
regulatory elements near posttranslational-modifying enzymes
have come under in placental animals (Lowe et al., 2011).
Here, we combined an efficient method for protein extraction
from tissue samples with lysine-acetylated peptide immuno-
precipitation and high-accuracy tandem mass spectrometric
(MS/MS) measurements, which allowed us to generate an atlas
of lysine acetylation sites in 16 different rat tissues. Our acety-
lome data set expands the current number of lysine acetylation
sites by 4-fold and the number of acetylated proteins by 2-fold
(Choudhary et al., 2009; Wang et al., 2010; Weinert et al.,
2011). We achieved this by improving the antibody-based
enrichment protocol significantly, such that 40% of all tandem
mass spectra identify lysine-acetylated peptides. We mapCell Reports 2, 419–431, August 30, 2012 ª2012 The Authors 419
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Figure 1. Workflow for Acetylome Analysis of Rat Tissues
(A) A total of 16 tissues were isolated from 5 male rats; the tissues were snap
frozen, heat inactivated, homogenized, and solubilized. The extracted proteins
were digested with endoproteinase Lys-C and trypsin, and lysine-acetylated
peptides were enriched by immunoprecipitation. The acetylated peptide
mixtures were fractionated by SCX in a STAGE tip, and three pH elutions per
tissue were analyzed by high-resolution LC-MS/MS on a LTQ-Orbitrap Velos
instrument resulting in identification of a total of 15,474 lysine acetylation sites
from 4,541 proteins.
(B) For liver and muscle samples, results from three technical replicates
prepared from the tissue homogenates are shown. Logarithmized intensities
for acetylated peptides were plotted against each other and shown on the left
side of the diagonal with the corresponding Pearson correlation coefficients
420 Cell Reports 2, 419–431, August 30, 2012 ª2012 The Authors3,000–6,000 acetylation sites in most tissues by analyzing
just three strong cation exchange (SCX) fractions with single
3 hr tandem mass spectrometric runs. We provide tissue-
specific evidence that lysine acetylation is comparable to
phosphorylation in cellular prevalence. Our data set highlights
tissue-specific pathways involving lysine-acetylated proteins,
which stresses the importance of mapping protein modifications
in the physiologically relevant tissue. Among the findings, we
observe that almost all proteins involved in striated muscle
contraction are acetylated, and we confirm this finding in human
skeletal muscle biopsies. Not only do we find that specific
proteins and sites are differentially acetylated across tissues,
we also show that the distribution of lysine-acetylated proteins
in subcellular compartments is tissue specific. Our large data
set allows us to delineate lysine acetylation sequence motifs,
and contrary to what has been previously known, we show that
there are subcellular compartment-specific sequence motifs.
We provide easy access to all data via a searchable online
database.RESULTS
Identification of 15,474 Lysine Acetylation Sites
from 4,541 Proteins
A total of 16 different organs and tissues were dissected from
Sprague-Dawley albino rats (SPRD; Taconic, Denmark) to
map lysine acetylation sites of proteins across tissues. The
tissues were brain, heart, muscle, lung, kidney, liver, stomach,
pancreas, spleen, thymus, intestine, skin, testis, testis fat, perire-
nal fat, and brown fat (Figure 1A). Organs from five rats were
pooled to account for biological variation. Protein extracts
were digested in solution in a urea buffer with sequential steps
of Lys-C and trypsin incubations. The resulting peptides were
desalted and enriched for lysine-acetylated peptides by immu-
noprecipitation followed by fractionation by microscale SCX
chromatography (Weinert et al., 2011). The three resulting SCX
fractions were analyzed by 3 hr nanoflow liquid chromatography
tandem mass spectrometry (LC-MS/MS) gradients on a LTQ-
Orbitrap Velos mass spectrometer (Olsen et al., 2009) with all
tandem mass spectra recorded in the orbitrap analyzer at high
resolution using the higher-energy collisional dissociation
(HCD) technology (Olsen et al., 2007). Peptide sequences were
identified by Mascot, and lysine-acetylated proteins were quan-
tified using the MaxQuant software suite’s label-free algorithm
based on peptide-extracted ion chromatograms (XICs). In total
1,060,605 high-resolution HCD-MS/MS events were collected
resulting in 265,034 peptide-spectrum matches at a false
discovery rate below 0.01. A total of 105,904 HCD spectra
identified lysine-acetylated peptides, which corresponds to
40% of all MS/MS identifications. The data set covered 62,553
unique modification-specific peptides, of which 19,965 were
lysine acetylated, matching to 15,474 lysine acetylation sites
from 4,541 proteins.given on the right side of the diagonal. Technical replicates of the same tissue
are highly correlated.
See also Figures S1 and S2.
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Figure 2. Tissue Distribution of Lysine-
Acetylated Proteins
(A) Hierarchical clustering of the 16 investigated
tissues and the identified acetylated proteins
based on label-free quantification on their sum-
med MS peptide signal intensities. Low-intensity
proteins are depicted in blue, and high-intensity
proteins are depicted in yellow. Protein clusters of
highly abundant acetylated proteins are high-
lighted by red boxes. The table summarizes the
number of lysine-acetylated proteins and sites
identified in each tissue as well as the average
number of acetylation sites per protein.
(B) Pathway enrichment analysis for all identified
acetylated proteins as well as for acetylated
proteins enriched in the main tissue clusters
compared to all other tissues. Logarithmized cor-
rected p values for significant overrepresentation
are shown. In parenthesis we indicate how many
proteins in each pathway we identify to be acety-
lated.
See also Figure S3.To facilitate the ease of searching the data set for modifica-
tions on particular proteins of interest, we have created an online
database, the CPR PTM Resource, where we have recorded
the entire tissue-specific lysine acetylation data set. At the
CPR PTM Resource, information on the tissue distribution of
posttranslational modifications on a given protein is provided
along with topological protein information imported from other
sources. To further allow for easy meta-analysis of the data set
for the scientific community, we provide 60 raw files as well
as 22,789 annotated lysine-acetylated peptide HCD-MS/MS
spectra as a resource for download via TRANCHE (see Extended
Experimental Procedures). Tables with all modification-specific
peptides (Table S1), identified lysine acetylation sites (Table
S2), and proteins (Table S3) are also provided both in the
Extended Experimental Procedures and at the CPR PTM
Resource website. Evaluation of the high-quality mass spec-
trometry (MS) and MS/MS data is shown in Figure S1. Figure S2Cell Reports 2, 419–431illustrates our successful enrichments of
lysine-acetylated peptides and peptide
fractionation, which were instrumental
factors, for allowing us to expand the
current number of lysine acetylation sites
by 4-fold.
Distribution of Lysine Acetylation
Sites across Tissues
For individual tissues there is excellent
technical reproducibility of the entire
experimental workflow (Figure 1B). Fig-
ure 1B summarizes three technical repli-
cates for two different tissue types: liver,
which is known to have high abundance
of lysine-acetylated proteins; and skeletal
muscle, which has not previously been
studied in the context of lysine acetyla-
tion. The correlation analysis of lysine-acetylated peptide MS signal intensities between technical
replications prepared from the same tissue reveals Pearson
coefficients < R > = 0.95 for liver and < R > = 0.91 for muscle.
Importantly, there is poor correlation between muscle and liver
tissues: < R > = 0.37. The high reproducibility of the MS data
collected from a given tissue enables us to perform relative
label-free quantification of lysine acetylation sites between
tissues. We evaluated the tissue distribution of lysine-acetylated
proteins by hierarchical clustering analysis of normalized
acetylated protein intensities derived from summed MS signal
intensities from each tissue (Figure 2A). The acetylated proteins
are color coded according to their normalized intensities, which
are a measure for their relative abundances in each tissue (de
Godoy et al., 2008; Malmstro¨m et al., 2009). Protein acetylation
patterns vary greatly across tissues, but functionally related
tissues cluster together, as for instance the major energy-
consuming tissues (heart, muscle, and brown fat) and organs, August 30, 2012 ª2012 The Authors 421
containing lymphoid tissue (lung, spleen, thymus, pancreas,
and intestine). Because we identify most high-abundant
proteins to be acetylated, this clustering profile is likely partly
due to similarities in protein expression patterns, in addition
to similarities in acetylation patterns. For most tissues we iden-
tify on the order of 1,000 lysine-acetylated proteins, but a few
tissues display significantly more acetylated proteins. For
example in kidney there are 2,061 acetylated proteins contain-
ing 6,283 modified residues (Figure 2A). To explore the differ-
ences underlying the tissue-specific patterns of acetylated
proteins in each tissue cluster, we performed gene ontology
(GO) (Ashburner et al., 2000) and pathway (Reactome) (Croft
et al., 2011) enrichment analyses. Testing which pathways are
enriched in the entire data set of 4,541 acetylated proteins iden-
tifies the main pathways previously recognized to be regulated
by lysine acetylation such as gene expression, protein metabo-
lism, the citric acid (TCA) cycle, and apoptosis (Figure 2B).
However, focusing on the acetylated proteins that are specifi-
cally enriched for each of the tissue clusters identifies tissue-
specific pathways, which for the most part have not previously
been shown to involve lysine acetylation. In general the tissue-
specific pathways correlate well with the known physiological
roles of the tissues, which possibly reflect that the high-abun-
dant acetylated proteins are expressed in a tissue-specific
manner. For instance the cluster with the major energy-
consuming tissues is significantly enriched for proteins involved
in striated muscle contraction as well as respiratory electron
transport. Conversely, the cluster with organs containing
lymphoid tissue is significantly enriched for proteins involved
in various aspects of transcription and translation. The acety-
lated proteins that are more abundant in the brain than in
other tissues are primarily involved in neuronal signal trans-
mission, whereas the specific acetylated proteins of the
stomach, liver, and kidney are enriched for proteins involved
in metabolism of amino acids and vitamins (Figure 2B).
Thus, lysine acetylation is targeting tissue-specific biological
processes, and it is involved in diverse cellular functions across
tissues.
As a starting point for deciphering tissue-specific molecular
networks of lysine-acetylated proteins, we generated protein-
protein interaction networks based on proteins that are acety-
lated in a tissue-specific manner. We identified interaction
partners using the InWeb database of quality-controlled
protein-protein interactions (Lage et al., 2007, 2008, 2010) and
applied a network-building algorithm to build protein-interaction
networks with quality thresholds optimized by permutation tests
(Bergholdt et al., 2007; Lage et al., 2010). Five of the protein-
interaction networks of tissue-specific acetylated proteins
interact significantly (0.0261 % adj. p % 0.0467, adjusted for
multiple testing using a Bonferroni correction), indicating that
proteins with tissue-specific acetylation patterns have a strong
tendency to directly interact or are part of connected tissue-
specific pathways. The high connectivity in interaction space
of acetylated proteins is clearly illustrated in the network
based on proteins specifically acetylated in brain (Figure S3).
We provide all networks in flat file and Cytoscape session
formats as a resource for the community through the CPR
PTM Resource web page.422 Cell Reports 2, 419–431, August 30, 2012 ª2012 The AuthorsLysine Acetylation in Rat and Human Striated Muscle
Contraction
To investigate one of the tissue-specific roles of lysine acetyla-
tion further, we decided to focus on striated muscle contraction.
More than 80% of the proteins involved in striated muscle
contraction are acetylated (Figure 3A). To ensure that this finding
is of general physiological relevance, we performed similar
experiments on human skeletal muscle biopsies from three
age-matched athletes. From these samples we assess the bio-
logical variation of lysine acetylation site abundance. Pearson
correlation coefficients range from 0.81 to 0.90 (Figure 3B),
thus indicating that it will be possible to perform quantitative
lysine acetylation analyses of human samples, and not only
from inbred animals. From the human skeletal muscle samples,
we identify a total of 941 acetylated proteins containing 2,811
acetylation sites (Table S4). The lysine acetylation sites identified
in human skeletal muscle confirm the acetylation pattern of
proteins involved in muscle contraction. In muscle the cellular
compartment with the highest abundance of lysine acetylation
is the mitochondria, and in rat as well as in human muscle
samples, we identify lysine acetylation sites on proteins involved
in all enzymatic steps of the major mitochondrial metabolic
pathways (Figure 3C). Thus, proteins involved in muscle con-
traction are hyperacetylated as are the metabolic enzymes
generating ATP, which collectively points to an important role
of lysine acetylation in skeletal muscle physiology.
Functional Analysis of Site-Specific Acetylation Sites on
Glycolytic Enzymes
In accordance with the increasing evidence that supports lysine
acetylation as amajor cellular mechanism that regulates glucose
metabolism (Wang et al., 2010; Yang et al., 2011; Zhao et al.,
2010), we identify multiple acetylation sites on enzymes involved
in the glycerol synthesis pathway. Interestingly, there is a tissue-
specific distribution of sites between the enzymes in human
skeletal muscle, rat brain and rat liver (Figure 4A). We identified
all three genetically distinct and tissue-specific isozymes of
fructose-bisphosphate aldolase known in mammals, with
specific acetylated peptides from ALDOA in human muscle,
ALDOB in liver, and ALDOC in brain. Aldolase deficiency in hu-
mans leads to fructose intolerance, and two-thirds of patients
suffering from hereditary fructose intolerance have a common
missense mutation in the ALDOB gene resulting in an amino
acid substitution A150P (Davit-Spraul et al., 2008). This mutation
is in close proximity of lysine 147 (K147), which we find to be
abundantly acetylated in intestine, stomach, kidney, and liver
(Figure 4B). To estimate the occupancy of this lysine acetylation
site, wemodified amethodwe previously developed to calculate
phosphorylation site occupancy from SILAC-labeled samples
(Olsen et al., 2010). Our approach relies on the label-free quan-
tification measurements and uses the information contained
in the normalized peptide intensities for a given acetylated
peptide and its corresponding nonacetylated peptide combined
with relative iBAQ estimated protein abundances between
tissues (Schwanha¨usser et al., 2011). Our occupancy calcula-
tions show that K147 is acetylated on 33% of the ALDOB
proteins in the liver and on20% of the proteins in the stomach,
thus indicating a potential physiological role. K147 as well as
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Figure 3. Lysine Acetylation in Muscle Contraction
(A) All proteins associated with striated muscle contraction were extracted from the Reactome pathway database, and a protein-protein interaction network was
visualizedwithSTRING (Szklarczyket al., 2011). Each yellowcircle represents aunique lysineacetylation site identified from rat skeletal or cardiacmuscle samples.
(B) Correlation plots of lysine-acetylated peptide intensities from skeletal muscle samples from three human individuals. The Pearson correlation coefficient is
provided in each plot.
(C) Four major mitochondrial metabolic pathways are depicted with the most acetylated protein identified in skeletal muscle for each enzymatic step in the
pathways. The metabolic pathways of amino acid catabolism and fatty acid metabolism generate acetyl-CoA that is feeded into the TCA cycle. The TCA cycle
generates NADH and FADH2, which serve as electron donors in the respiratory chain, ultimately resulting in the formation of ATP. All enzymes are represented by
their gene names, and below each enzyme the number of identified lysine acetylation sites is given for rat and human muscle samples, respectively (rat/human).
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Figure 4. Functional Analysis of Site-Specific Acetylation Sites on Glycolytic Enzymes
(A) Tissue distribution of lysine acetylation sites on enzymes involved in glycerol synthesis. For each enzymatic step, enzymes from human skeletal muscle (blue),
rat brain (purple), and rat liver (green) are visualized with the number of lysine acetylation sites identified (yellow). For aldolase (ALDOA, ALDOB, and ALDOC) and
phosphofructosekinase (PFKM, PFKC, and PFKL), tissue-specific isozymes were identified and are boxed in red color.
(B) Tissue distribution of the mass spectrometric signal intensities of the ALDOB K147-acetylated peptide DGVDFGK(ac)WARAVLR.
(C) Conservation of rat ALDOB K147 across species from human to probacteria and plants.
(D) Catalytic activity of ALDOB WT and ALDOB K147Q toward fructose-1,6-bisphosphate assayed by downstream NADH oxidation, respectively (n = 3,
mean ± SEM). The activity of ALDOB K174Q was below the assay detection limits of approximately 1 3 104 mmol/min/mg.
(E) Enzymatic activity of GPD1WT and GPD1 K120Q toward dihydroxyacetone phosphate measured by NADH oxidation, respectively (n = 3, mean ± SEM). The
activity of GPD1 K120Q was below the assay detection limit of approximately 5 3 104 mmol/min/mg.
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the surrounding amino acids is highly conserved from verte-
brates to probacteria (Figure 4C). Because K147 furthermore is
important for substrate binding (St-Jean et al., 2009), we decided
to investigate functional effects of acetylation of this residue
on ALDOB enzymatic activity. We expressed full-length human
ALDOB in a wild-type and K147Q acetylation mimetic mutant
and measured the enzymatic activity of the purified proteins.
Wild-type ALDOB efficiently converts fructose-1,6-bisphos-
phate to glyceraldehyde-3-phosphate and dihydroxyacetone
phosphate at a rate of 0.34 ± 0.01 mmol/min/mg. Strikingly, the
K147Q mutation appears to abolish the enzymatic activity of
ALDOB because this mutant shows no detectable activity in
our assay (Figure 4D). Hence, the wild-type enzyme is at least
three orders of magnitude more active than the K147Q mutant.
This finding highlights that site-specific acetylation can function
as an efficient cellular mechanism to switch off the enzymatic
activity of important regulatory proteins. To investigate if this
regulatory switch is restricted to aldolases, or if lysine acetylation
of substrate binding sites is a general mechanism to inhibit
enzymes in the glycogen synthesis pathway, we tested the
function of an equivalent lysine acetylation site we identified on
glycerol-3-phosphate dehydrogenase (GPD1). K120 on GPD1
is predicted to serve as a substrate binding site (Ou et al.,
2006), and we identified this residue to be acetylated. Analogous
to the functional test of ALDOB, we purified wild-type GPD1
as well as the K120Q mutant and assayed their enzymatic
activity (Figure 4E). The activity of wild-type enzyme was
measured to 4.4 ± 0.4 mmol/min/mg, whereas the acetylation
mimicking mutated enzyme has activity levels below the detec-
tion limit. The difference in activity between the wild-type and
mutant GPD1 is more than three orders of magnitude, thus again
providing evidence for lysine acetylation as a mechanism for
switching off enzymatic activity.
Cellular Compartment Distribution of Lysine-Acetylated
Proteins
To investigate the distribution of acetylated proteins across
cellular compartments, we evaluated the proteins according
to their GO cellular compartment annotations. The majority of
acetylated proteins reside in either the cytoplasm or the nucleus,
which each contain 30% of all the acetylated proteins. The
mitochondria and the plasma membrane both account for
15% of modified proteins, and the endoplasmic reticulum or
Golgi apparatus (ER/Golgi) as well as the extracellular space
harbor 5% (Figure 5A). Two tissue atlases of phosphoproteins
have been published, one for mouse and one for rat (Huttlin et al.,
2010; Lundby et al., 2012), so to compare the distribution of
phosphoproteins to that of acetylated proteins, we exploited
the rat data set we have generated. Interestingly, the subcellular
distribution of acetylated proteins is markedly different from the
distribution of phosphorylated proteins (Figure S4). The fraction
of modified proteins residing in the mitochondria is more than
3-fold higher for lysine-acetylated proteins compared to phos-
phorylated proteins. On the contrary the fraction of protein
substrates localized to the plasma membrane is more than
2-fold higher for phosphorylation compared to acetylation.
However, the subcellular distribution of lysine-acetylated pro-
teins is tissue dependent and possibly reflects the distributionof unmodified proteins. For example the brain accounts for the
largest fraction of acetylatedmembrane proteins, which explains
why pathway enrichment analysis of all acetylated plasma
membrane proteins emphasizes neurophysiological functions
(Figure 5B). Alike, the three adipose tissues are abundant in
acetylated proteins associated with the extracellular space,
which is likely associated to adipose tissues being major endo-
crine organs (Kratchmarova et al., 2002; Saltiel, 2001). Organs
containing lymphoid tissue (spleen, thymus, pancreas, lung,
and intestine) contain a higher fraction of acetylated nuclear
proteins than any of the other tissues, and these nuclear proteins
are significantly enriched for sequence-specific DNA binding
transcription factor activity (p = 9 3 104). Focusing on the
proteins underlying this enrichment, we discover that lysine
acetylation is significantly more abundant on 82 of 129 modified
transcription factors in these tissues (Table S5). This observation
likely reflects that lymphoid-containing tissues have high self-
renewal rates (Pellettieri and Sa´nchez Alvarado, 2007) and,
therefore, require high transcriptional activity.
At the global level we identify an average of 2.8 lysine acety-
lation sites per protein per tissue (Figure 2A), but as evident
from Figure 5A, this number greatly varies between cellular
compartments. Mitochondrial proteins exhibit the greatest
number of acetylation sites with an average of 5.6 sites per
protein. This may explain why many previous studies primarily
identified acetylation sites frommitochondrial proteins, although
this is not the compartment with the greatest number of acety-
lated proteins. To test if the tendency toward multiacetylated
proteins in the mitochondria is biased by protein abundance,
we estimated the relative protein abundance for all proteins
using the iBAQ method. Analyzing the number of acetylation
sites per protein as function of protein abundance revealed
that mitochondrial proteins have significantly more modified
sites at all protein abundance levels (Figure S5). The tissues
with the largest fraction of acetylated mitochondrial proteins
are muscle, heart, and brown fat. More than 35% of all identified
acetylation sites in these tissues are mitochondrial, with a signif-
icant overrepresentation of proteins involved in the electron
transport chain (p = 7 3 103). Thus, the result likely reflects
the high-energy demand and oxidative capacity of these partic-
ular tissues.
Lysine Acetylation Sequence Motifs Are Specific
for Cellular Compartments
We explored our data set for lysine acetylation site-specific
sequence motifs by analyzing the 12 residues flanking the modi-
fied site for overrepresentation of specific amino acids relative
to the proteome background distribution. Analysis of all identi-
fied acetylation sites reveals general preferences for specific
amino acid residues at particular positions surrounding the
acetylated lysines (Figure 6A). As also previously reported
(Weinert et al., 2011), we find that lysine acetylations preferen-
tially occur in lysine-rich regions, with a tendency toward nega-
tively charged residues in the immediate surroundings of the
modified site. Position-specific preferences include glycine
residues at amino acid position 1 relative to the acetylated
residue, proline/phenylalanine/tyrosine residues at amino acid
position +1, and valine/isoleucine residues at amino acidCell Reports 2, 419–431, August 30, 2012 ª2012 The Authors 425
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See also Figures S4 and S5.
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Figure 6. SequenceMotifs for Lysine Acety-
lation Sites across Cellular Compartments
(A) Heatmap indicating overrepresentation of
amino acids in positions from 6 to +6 from the
acetylated lysine residue based on all identified
acetylation sites compared to the overall pro-
teome amino acid frequency distribution.
(B) Sequence logos for acetylation sites identified
on proteins residing in the nucleus, cytosol, mito-
chondria, or ER-Golgi.
(C) Sequence logos for subsets of the nuclear
proteins. Sites identified from histones and tran-
scription factors were analyzed separately.
(D) Table summarizing sequence motifs found for
compartment-specific lysine acetylation sites with
sequence motif and tissue enrichment p values
indicated.
See also Figure S6.position +2. We next investigated if these sequence preferences
are similar across all cellular compartments. Interestingly, the
global sequence motif map we find appears to be a merged
picture of compartment-specific motifs (Figure S6). To visualize
compartment-specific sequence motifs, we analyzed all lysine
acetylation sites from proteins localized to a particular subcel-
lular compartment relative to the rat protein database using ice-
Logo (Colaert et al., 2009) (Figure 6B). This analysis reveals that
the sequence motifs indeed differ for subcellular compartments.
The preference for lysine-rich regions is general to all compart-
ments, but on cytoplasmic proteins there is a clear preference
for glutamate residues at all positions in the vicinity of the
acetylation site. Mitochondrial proteins have a preference for
negatively charged residues in the immediate vicinity of the
acetylation site, but they additionally show a strong preference
for hydrophobic residues (V/I/L/F) at position +2. Proteins that
reside in either ER/Golgi also have the general preference for
negatively charged residues but further favor hydrophobic resi-
dues (I/L) at positions 1 and 2. The most distinct sequenceCell Reports 2, 419–431motif is evident on nuclear proteins,
where there is a strong preference for
glycine residues in position 1 and
proline residues in position +1. Because
this nuclear sequence motif differs
substantially from the previously reported
motif for lysine acetylation of histones (K-
X-X-X-AcK-X-X-X-K) (Kim et al., 2006),
we next analyzed sites identified from
histones separately. This analysis indeed
confirms that the preferred sequence
motif for histones differs from other
nuclear proteins and that it conforms to
the known motif with lysines at positions
±4 (Figure 6C). Another group of nuclear
proteins of particular interest is transcrip-
tion factors, and because we have identi-
fied a total of 388 acetylation sites on
transcription factors, we next tested if
these contain a particular sequencemotif. We find that transcription factors display a similar motif
as the other nuclear proteins (G-AcK-P), which thus differs for
the one found for histones (Figure 6C). The identified compart-
ment-specific sequence motifs are summarized in Figure 6D.
DISCUSSION
The importance of tissue-specific mapping of posttranslational
modifications of proteins is underscored by the substantial
differences we find for lysine acetylation patterns across tissues.
Our data set provides a rich resource of candidates for hypoth-
esis generation and subsequent mechanism-focused studies
to elucidate the tissue-specific protein networks that are
controlled by regulatory site-specific lysine acetylation. In addi-
tion the data set provides evidence that site-specific lysine-
acetylated proteins are involved in multiple physiological
functions with which the modification has not previously been
associated. For example we show that almost all proteins
involved in muscle contraction are acetylated both in rat striated, August 30, 2012 ª2012 The Authors 427
muscle as well as in human skeletal muscle. In particular we
find that multiple enzymes involved in ATP generation are hyper-
acetylated in skeletal muscle mitochondria, for many of which
it is known that the enzymatic activity of their bacterial orthologs
is regulated by lysine acetylation (Wang et al., 2010). Because
acetylation of muscle LIM protein is moreover known to enhance
calcium sensitivity of myofilaments in cardiomyocytes (Gupta
et al., 2008), our findings strongly imply that muscle-contractile
proteins are regulated by lysine acetylation in addition to the
well-established role of phosphorylation in muscle contraction.
This notion is further supported by our demonstration that site-
specific acetylation of two glycolytic enzymes, ALDOB and
GPD1, serves as a regulatory mechanism for switching off
their enzymatic activity. It is intriguing to speculate that lysine
acetylation of substrate binding sites may be a general cellular
mechanism to control metabolic enzyme activity in a manner
analogous to phosphorylation-dependent regulation of protein
kinases and signal transducers. In contrast to the activating
effects of phosphorylation, acetylation could function to switch
off enzymatic activity, adding another layer of posttranslational
regulatory control to dynamic cellular processes.
Formore than a decade, it has been speculated that the extent
of lysine acetylation matches that of phosphorylation (Kouzar-
ides, 2000). With this data set we provide evidence that this is
indeed the case. Intriguingly, despite the observation that phos-
phorylation and acetylation both have broad cellular scopes,
we have shown that they have distinct subcellular substrate
patterns. On average the fraction of lysine-acetylated proteins
that reside in the mitochondria is three times greater than that
of phosphorylated proteins. Conversely, the fraction of phos-
phorylated proteins at the plasma membrane is twice as high
as that of acetylated proteins. However, the subcellular distri-
bution of lysine acetylation sites varies across tissues. Lysine
acetylation is in general abundant in mitochondria, a large frac-
tion of mitochondrial proteins carry the modification, and the
average number of modified sites per protein is high, but the
modification is particularly prevalent in mitochondria of energy-
generating tissues. In brown fatmore than 50%of the acetylation
sites we identified reside on mitochondrial proteins. Among
the sites are three modifications on the uncoupling protein 1
(ucp1), which is essential for the tissue’s ability to dissipate
energy as heat. Our data also reveal that the amino acids flanking
the modified sites in brown fat mitochondria exhibit two sig-
nificant sequence motifs: D-X-X-AcK and AcK-X-I.
Lysine acetylation has not previously been discussed in the
context of secreted proteins, but we identify about 200 extra-
cellular proteins that carry the modification. These proteins
were primarily identified in adipose tissues, which likely reflect
that adipose tissues are major endocrine organs (Kratchmarova
et al., 2002; Saltiel, 2001). The functional roles of these lysine
acetylation sites remain to be elucidated, as is also the case
for the sites on the more than 400 plasma membrane proteins
that we here show carry the modification. ER preparations
purified from a human cell line were recently investigated in the
context of lysine acetylation (Pehar et al., 2012). A total of 143
acetylated proteins were identified, which is about half the
number reported herein. Two proteins highlighted in the study,
GRP78 and CALR, were reported to harbor six and five acetyla-428 Cell Reports 2, 419–431, August 30, 2012 ª2012 The Authorstion sites, respectively. Although we have better coverage in our
study, identifying 20 and 13 sites, respectively, a couple of sites
reported by Pehar et al. (2012) were not covered in our data set.
Artificial acetyl group transfers can be introduced in vitro by
nonenzymatic reactions (Dormeyer et al., 2005) or by changes
to a protein’s C terminus (Pasheva et al., 2004). To prevent false
positives, nonenzymatic acetylation should therefore be consid-
ered in the evaluation of in vitro studies of acetylated peptides.
Pehar et al. (2012) investigated ERs purified from cells overex-
pressing an ER membrane acetyl-CoA transporter, which led
to increased ER acetylation compared to endogenous levels.
For GRP78 and CALR their acetylation profiles were further
investigated by analyses of overexpressed C terminus-tagged
proteins. The differences between the results of Pehar and
colleagues and the results in this study could therefore either
be a result of false positives introduced by the high levels of
acetyl-CoA in their cell system, a change in the C terminus of
the two proteins, or simply reflect that our compendium is not
yet comprehensive.
The highest fractions of nuclear acetylation sites were identi-
fied in the lymphoid-containing organs, which are known to
have high mitotic activity. The acetylation level of K19 and K24
on histone H3 correlates with transcriptional activity, and intrigu-
ingly, these particular sites are most abundant in the lymphoid
tissues, such as thymus and spleen, that primarily consist of
dividing cells with active cell-cycle machinery. There is further
evidence in our data set for this observation by a significant
overrepresentation of lysine acetylation-modified transcription
factors in the same lymphoid tissues. For a few transcription
factors, such as p53, RELA, and STAT3, it is already known
that they are functionally regulated by lysine acetylation (Gu
and Roeder, 1997; Hoberg et al., 2006; Wang et al., 2005). Our
identification of a total of 388 acetylation sites on transcription
factors indicates that lysine acetylation may be a more ubiqui-
tous mechanism of transcription factor regulation than previ-
ously appreciated. The notion that the modified sites are more
prevalent in mitotic compared to postmitotic tissues, such as
brain and heart muscle, further favors a functional role of these
sites. In the lymphoid tissues we identify significant nuclear
sequence motifs for lysine acetylation sites. We show that
although lysine acetylation sites on histones exhibit the motif
K-X-X-X-AcK-X-X-X-K, sites on nuclear proteins in general and
on transcription factors, in particular, exhibit preference for the
motif G-AcK-P. A glycine at position 1 has previously been
demonstrated to be part of a recognition motif for the nuclear
CBP/p300 lysine acetyl transferase (KAT) complex (Bannister
et al., 2000), and a high-resolution crystal structure of the KAT
domain of the STAGA transcription coactivator-complex
member GCN5 bound to either coenzyme A or a histone H3
peptide also revealed binding specificity for a random coil struc-
ture with this motif (Rojas et al., 1999), thus supporting the
functional relevance of glycine preceding lysine as part of a
nuclear recognition motif.
Our finding that lysine acetylation sequence motifs are
compartment specific favors the debated existence of subcel-
lular compartment-specific KATs (Sadoul et al., 2011). Although
a mitochondrial KAT is further supported by our identification of
acetylation sites on four proteins encoded by mitochondrial
DNA, we cannot rule out the possibility that the sequence motifs
are due to compartment-specific protein expression patterns.
The observed sequence preferences could also in part be
mediated by lysine deacetylates (HDACs). HDAC inhibitors are
promising therapeutic agents for treatment of a variety of
cancers (Marks et al., 2001). Nevertheless, the underlying
molecular mechanisms and effects of the clinically administered
HDAC inhibitors are largely unknown. It would not only be of
high medical relevance to probe patient tumor samples for
aberrant acetylation patterns, but delineating downstream in vivo
targets of HDAC inhibitors is of equal importance. Therefore, we
are confident that the methodology we have developed and
applied to investigate lysine acetylation sites in tissue samples
will open new avenues for large-scale investigations of lysine
acetylation patterns in disease tissues and for phenotyping
samples from patients with cancer.
EXPERIMENTAL PROCEDURES
See Extended Experimental Procedures for detailed Experimental
Procedures.
Rat Tissues and Peptide Extraction
Organs were quickly dissected from five Sprague-Dawley rats and snap
frozen. Following heat inactivation tissues were homogenized and sonicated,
proteins were acetone precipitated, resuspended in urea, and the concen-
tration was determined. Proteins were reduced, alkylated, and digested with
endoproteinase Lys-C followed by trypsin. Samples were desalted, and
acetylated peptides were enriched using agarose-conjugated acetyl lysine
antibody and separated by SCX fractionation before loading onto in-house
packed C18 STAGE tips.
MS
Eluted peptide mixtures were reconstituted in 2% MeCN, 0.5% AcOH, 0.1%
TFA, and separated by online reversed-phase C18 nanoscale liquid chroma-
tography on a 15 cm 3 75 mm column packed with ReproSil-Pur C18-AQ
3 mm resin. A nanoflow EASY-nLC system (Proxeon Biosystems, Odense,
Denmark) was connected through a nano-electrospray ion source to the
mass spectrometer. Peptideswere separated by a linear gradient of increasing
acetonitrile in 0.5% acetic acid for 180 min with a flow rate of 250 nl/min. The
MS/MS was performed on a LTQ Orbitrap Velos mass spectrometer (Thermo
Electron, Bremen, Germany) using a top10 HCD fragmentation method. Full-
scan MS spectra were acquired at a target value of 1e6 and a resolution of
30,000, and the HCD-MS/MS spectra were recorded at a target value of 5e4
and with a resolution of 7,500 using normalized collision energy of 40%.
Raw MS files were processed using the MaxQuant software (ver.1.0.14.7
and v.1.2.0.29). Precursor MS signal intensities were determined, and HCD
MS/MS spectra were deisotoped and filtered such that only the ten most-
abundant fragments per 100 m/z range were retained. Acetylated proteins
were identified using the Mascot search algorithm. HCD-MS/MS spectra
were searched with fixedmodification of Carbamidomethyl-Cysteine and vari-
able modifications of oxidation (M), acetylation (protein N-term), Gln- > pyro-
Glu, and acetylation (K). Initial precursor ion tolerance was 7 ppm, MS/MS
tolerance 0.02 Da, and strict tryptic specificity with maximum two missed
cleavages were required. Label-free quantification and validation were per-
formed in MaxQuant. Acetylated peptides were filtered based on Mascot
score, PTM (Andromeda) score, precursor mass accuracy, peptide length,
and summed protein score to achieve an estimated FDR <0.01 based on
forward and reversed identifications. Hierarchical clustering was performed
in Perseus (Max-Planck Institute of Biochemistry, Department of Proteomics
and Signal Transduction, Munich) using Euclidian distance and average
linkage clustering. Statistical evaluation of enriched Reactome pathways
and GO terms for biological processes identified with the innateDB web
tool (Lynn et al., 2008) were performed using a hypergeometric test andcorrecting for multiple testing by applying a Benjamini-Hochberg false
discovery rate of 0.01. Sequence motif analysis was performed with iceLogo
using percent difference as scoring system and applying a significance cutoff
of 0.01.
Enzymatic Experiments
The coding sequences for human ALDOB and GPD1were cloned into
pDEST-15, point mutations were introduced, and constructs were trans-
formed into Rosetta cells. Recombinant proteins were extracted and incu-
bated with glutathione Sepharose beads. The concentrations of purified
proteins were determined, and the amino acid sequences were checked by
MS. Enzymatic activities were determined as initial velocity measurements
by monitoring NADH decrease as a function of time at 340 nm absorbance
reads on a Biotek Synergy H4 reader.
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